Blephacura Versus Baby Shampoo to Treat Blepharitis
NCT01115192 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144
Last updated 2018-11-19
Summary
The aim of the study is to compare the effectiveness in treatment of chronic blepharitis either with a phospholipid liposome suspension compared to a conventional therapy recommendation using diluted baby shampoo.
Conditions
- Blepharitis
Interventions
- PROCEDURE
-
Group A
Blephacura is a solution with liposomes and used for cleaning of the eye lid to treat blepharitis
- PROCEDURE
-
Group B
Diluted Baby Shampoo is used for cleaning of the eye lid to treat blepharitis
Sponsors & Collaborators
-
Optima Pharmazeutische GmbH
collaborator UNKNOWN -
University of Cologne
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-01
- Primary Completion
- 2010-12-31
- Completion
- 2010-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Efficacy and Tolerability of Blephademodex Wipes
NCT04780165 ·Status: COMPLETED ·Phase: NA
-
Comfort Associated With The Use Of Eyelid Cleansing Products Available For The Management Of Demodex Folliculorum
NCT03987230 ·Status: COMPLETED ·Phase: NA
-
0.01% Hypochlorous Acid in the Treatment of Blepharitis
NCT05608980 ·Status: UNKNOWN ·Phase: NA
-
TTO Swabs Versus Baby Shampoo in Patients With Seborrehic Blepharitis
NCT04678531 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
NCT00423007 ·Status: COMPLETED ·Phase: PHASE3
-
Tea Tree Oil in the Treatment of Chronic Blepharitis
NCT01073150 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children
NCT01023841 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Stinging Potential of Products in Human Eyes
NCT02872194 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Stinging Potential in Human Eyes
NCT02872207 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
NCT06911424 ·Status: RECRUITING ·Phase: PHASE3
-
Topical IL-1-Ra for Treatment of Posterior Blepharitis
NCT00681109 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
NCT01743027 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis.
NCT06720896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
NCT00349466 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis
NCT01391286 ·Status: COMPLETED ·Phase: PHASE3
-
Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis
NCT01330355 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis
NCT01357538 ·Status: COMPLETED ·Phase: PHASE4
-
Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice
NCT01552174 ·Status: COMPLETED
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment
NCT06400511 ·Status: TERMINATED ·Phase: PHASE3
-
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
NCT01109485 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes
NCT02869113 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis
NCT00586664 ·Status: COMPLETED ·Phase: PHASE3
-
Warming Efficiency of Warm Compresses Versus BLEPHASTEAM® in Eyelid Therapy
NCT01190397 ·Status: COMPLETED ·Phase: PHASE1
-
Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
NCT01363700 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis
NCT01037179 ·Status: COMPLETED ·Phase: PHASE3